Catherine Pham, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 8 carriers
- Offices
- 2
- Since medical school
- 29 years
- University of California, Geffen School of Medicine, 1997
Offices
2 locations · Bdhv Medical Group of California PC · Ngoc Nguyen MD Inc
Looking this up.
Plans that list them
27 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pham’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$335,480
Medicare paid this office $335,480 for 836 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, aflibercept, 1 mg | 32 | $80,902 | None |
| Removal of cataract with insertion of prosthetic lens | 64 | $43,033 | $414 |
| Established patient complete exam of visual system | 220 | $21,518 | $93 |
| New patient complete exam of visual system | 208 | $20,722 | $100 |
| Injection of drug into eye | 96 | $20,099 | $93 |
See all 23 services
| Injection, aflibercept, 1 mg | 32 | $80,902 | None |
| Removal of cataract with insertion of prosthetic lens | 64 | $43,033 | $414 |
| Established patient complete exam of visual system | 220 | $21,518 | $93 |
| New patient complete exam of visual system | 208 | $20,722 | $100 |
| Injection of drug into eye | 96 | $20,099 | $93 |
| Short return visit (20+ min) | 214 | $18,754 | $71 |
| Imaging of retina | 296 | $15,386 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 42 | $14,578 | $251 |
| Established patient problem focused exam of visual system | 165 | $14,435 | $73 |
| Removal of excessive skin and fat of upper eyelid | 17 | $11,449 | $673 |
| Compounded drug, not otherwise classified | 62 | $10,362 | None |
| New patient visit (45+ min) | 46 | $5,748 | $125 |
| Return visit (30+ min) | 53 | $5,282 | $96 |
| Measurement of corneal curvature and depth of eye | 89 | $3,728 | $19 |
| New patient visit (30+ min) | 44 | $3,541 | $80 |
| Photography of the retina | 89 | $2,617 | $28 |
| New patient problem focused exam of visual system | 36 | $2,133 | $59 |
| Exam of visual field with extended testing | 27 | $1,457 | $50 |
| Removal of chronic growth of eyelid | 11 | $1,141 | $95 |
| Exam of visual field with limited testing | 37 | $938 | $25 |
| Imaging of optic nerve | 25 | $826 | $28 |
| Photography of content of eyes | 25 | $489 | $20 |
| Removal of eyelashes using forceps | 11 | $169 | $15 |
Procedures Medicare counted
| Cataract surgery | 31 | More than 54% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Procedures year by year
| Procedure | 2016 | 2017 | 2018 | 2019 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of drug into eye | 117 | 58 | – | – | – | 217 |
| Removal of cataract with insertion of prosthetic lens | 64 | 48 | – | – | – | 104 |
| Removal of recurring cataract in lens capsule using a laser | 21 | 39 | – | – | – | 58 |
| Removal of excessive skin and fat of upper eyelid | – | – | – | – | – | 17 |
| Removal of chronic growth of eyelid | – | – | – | – | – | 12 |
| Removal of eyelashes using forceps | – | – | – | – | – | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
836 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 14% · Women 60% · Also on Medicaid 19% · Health risk score 1.15. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 70% · Diabetes 34% · Chronic kidney disease 23% · Coronary heart disease 21% · Atrial fibrillation 18% · COPD 17% · Depression 17% · Heart failure 14% · Cancer 13% · Stroke 8% · Dementia 5%.
The office billed $755,960, Medicare allowed $436,806 and paid $335,480; for 3,493 services of 54 kinds; $99,019 of it was for drugs given in the office and $236,462 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 836 | 3,493 | 75 | 1.15 | $755,960 | $335,480 |
| 2023 | 49 | 175 | 73 | 1.47 | $34,925 | $8,119 |
| 2019 | 38 | 75 | 68 | 1.16 | $21,698 | $3,155 |
| 2018 | 114 | 260 | 76 | 1.04 | $54,346 | $15,891 |
| 2017 | 404 | 2,324 | 75 | 1.07 | $441,123 | $171,347 |
| 2016 | 487 | 3,176 | 74 | 1.21 | $634,838 | $252,641 |
| 2015 | 480 | 3,255 | 75 | 1.18 | $690,436 | $279,945 |
| 2014 | 373 | 1,856 | 74 | 1.02 | $475,641 | $192,658 |
| 2013 | 489 | 1,365 | 76 | 0.94 | $352,845 | $156,040 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Established patient problem focused exam of visual system | 22 | $2,062 | $53 |
| Established patient complete exam of visual system | 20 | $1,067 | $49 |
| Imaging of retina | 15 | $770 | $26 |
| Imaging of optic nerve | 12 | $168 | $14 |
2019: 2 services
| Established patient complete exam of visual system | 25 | $1,615 | $56 |
| Established patient problem focused exam of visual system | 14 | $745 | $47 |
2018: 4 services
| Established patient complete exam of visual system | 83 | $3,680 | $44 |
| Imaging of retina | 54 | $1,277 | $22 |
| Exam of visual field with extended testing | 24 | $864 | $36 |
| Imaging of optic nerve | 39 | $537 | $14 |
2017: 12 services
| Established patient complete exam of visual system | 334 | $60,919 | $82 |
| Removal of cataract with insertion of prosthetic lens | 30 | $24,197 | $504 |
| Imaging of retina | 335 | $18,700 | $29 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $9,908 | $254 |
| Established patient problem focused exam of visual system | 77 | $7,425 | $62 |
| New patient complete exam of visual system | 85 | $7,344 | $86 |
| Exam of visual field with extended testing | 114 | $6,194 | $49 |
| Imaging of optic nerve | 124 | $5,355 | $26 |
| Measurement of corneal curvature and depth of eye | 48 | $4,486 | $63 |
| Injection of drug into eye | 18 | $4,319 | $74 |
| Compounded drug, not otherwise classified | 13 | $2,713 | None |
| Ultrasound scan of cornea to determine thickness | 25 | $280 | $11 |
2016: 16 services
| Established patient complete exam of visual system | 400 | $84,383 | $88 |
| Removal of cataract with insertion of prosthetic lens | 45 | $31,569 | $493 |
| Imaging of retina | 388 | $30,460 | $34 |
| Established patient problem focused exam of visual system | 112 | $14,551 | $64 |
| New patient complete exam of visual system | 125 | $12,197 | $98 |
| Injection of drug into eye | 25 | $9,771 | $84 |
| Exam of visual field with extended testing | 143 | $8,414 | $50 |
| Compounded drug, not otherwise classified | 23 | $6,308 | None |
| Imaging of optic nerve | 133 | $6,117 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $5,740 | $273 |
| Measurement of corneal curvature and depth of eye | 59 | $5,467 | $60 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 24 | $3,863 | $80 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 14 | $3,361 | $210 |
| Photography of the retina | 16 | $995 | $62 |
| Ultrasound scan of cornea to determine thickness | 32 | $356 | $11 |
| Photography of content of eyes | 13 | $213 | $15 |
2015: 20 services
| Established patient complete exam of visual system | 354 | $72,052 | $91 |
| Removal of cataract with insertion of prosthetic lens | 63 | $50,068 | $533 |
| Imaging of retina | 388 | $31,464 | $36 |
| New patient complete exam of visual system | 186 | $19,562 | $105 |
| Established patient problem focused exam of visual system | 127 | $16,882 | $68 |
| Injection of drug into eye | 35 | $10,796 | $81 |
| Removal of recurring cataract in lens capsule using a laser | 28 | $9,866 | $274 |
| Exam of visual field with extended testing | 140 | $7,934 | $52 |
| Measurement of corneal curvature and depth of eye | 92 | $7,906 | $61 |
| Imaging of optic nerve | 122 | $5,616 | $34 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 28 | $4,654 | $83 |
| Unclassified biologics | 28 | $4,561 | None |
| Laser repair to improve eye fluid flow | 11 | $4,252 | $266 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 12 | $2,527 | $211 |
| Injection of drug or substance into membrane covering eyeball | 11 | $1,843 | $80 |
| Return visit (30+ min) | 20 | $1,432 | $68 |
| Photography of the retina | 18 | $1,403 | $61 |
| Compounded Drug, Not Otherwise Classified | 13 | $1,047 | $52 |
| Ultrasound scan of cornea to determine thickness | 33 | $378 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $43 | None |
2014: 18 services
| Established patient complete exam of visual system | 263 | $50,616 | $98 |
| Removal of cataract with insertion of prosthetic lens | 30 | $23,396 | $544 |
| New patient complete exam of visual system | 192 | $22,835 | $119 |
| Imaging of retina | 227 | $14,831 | $39 |
| Removal of recurring cataract in lens capsule using a laser | 30 | $10,593 | $279 |
| Removal of cataract with insertion of prosthetic lens | 15 | $10,450 | $550 |
| Laser repair to improve eye fluid flow | 12 | $6,136 | $292 |
| Exam of visual field with extended testing | 94 | $5,577 | $55 |
| Measurement of corneal curvature and depth of eye | 45 | $4,746 | $67 |
| Recording of retinal electrical responses to external stimuli | 24 | $3,402 | $136 |
| Imaging of optic nerve | 80 | $3,362 | $36 |
| Established patient problem focused exam of visual system | 36 | $3,289 | $71 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 17 | $3,102 | $89 |
| Nerve test | 25 | $3,030 | $117 |
| Injection of drug into eye | 18 | $2,502 | $86 |
| Unclassified biologics | 18 | $1,471 | None |
| Ultrasound scan of cornea to determine thickness | 44 | $510 | $11 |
| Photography of content of eyes | 12 | $201 | $17 |
2013: 11 services
| Established patient complete exam of visual system | 429 | $63,931 | $96 |
| Removal of cataract with insertion of prosthetic lens | 27 | $26,345 | $549 |
| Return visit (30+ min) | 121 | $16,695 | $81 |
| Removal of recurring cataract in lens capsule using a laser | 39 | $13,322 | $272 |
| Exam of visual field with extended testing | 129 | $8,334 | $57 |
| New patient complete exam of visual system | 50 | $5,939 | $119 |
| Measurement of corneal curvature and depth of eye | 27 | $2,449 | $54 |
| Ultrasound scan to determine eye length and lens power | 11 | $1,047 | $70 |
| Exam of the internal drainage system of eye | 29 | $893 | $23 |
| Photography of the retina | 12 | $863 | $66 |
| Short return visit (20+ min) | 12 | $684 | $57 |
Medicaid work
$5,233 in 2024
Medicaid paid $5,233 for 187 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 42 | $1,923 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 66 | $1,613 |
| Short return visit (20+ min) | 45 | $627 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 13 | $594 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 21 | $475 |
| 2024 | 187 | 5 | 21 | $5,233 |
| 2023 | 72 | 2 | 15 | $6,811 |
| 2019 | 12 | 1 | 12 | $1,815 |
| 2018 | 12 | 1 | 12 | $915 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 44 | $5,171 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 28 | $1,640 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $1,815 |
2018
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $915 |
Drugs they prescribed that Part D paid
$27,290
Pharmacies billed $27,290 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 632) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
400 generic and 232 brand-name prescriptions · $27,290 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 110 | $3,200 | $29 |
| Latanoprost | 135 | $2,133 | $16 |
| Dorzolamide-Timolol | 71 | $1,796 | $25 |
| Neomycin-Polymyxin-Dexameth | 93 | $1,052 | $11 |
| Brimonidine | 23 | $868 | $38 |
See all 10 drugs
| Prednisolone Acetate | 110 | $3,200 | $29 |
| Latanoprost | 135 | $2,133 | $16 |
| Dorzolamide-Timolol | 71 | $1,796 | $25 |
| Neomycin-Polymyxin-Dexameth | 93 | $1,052 | $11 |
| Brimonidine | 23 | $868 | $38 |
| Timolol Maleate | 22 | $387 | $18 |
| Diclofenac | 32 | $281 | $9 |
| Moxifloxacin | 13 | $242 | $19 |
| Erythromycin | 22 | $229 | $10 |
| Ofloxacin | 15 | $129 | $9 |
Year by year
| 2024 | 632 | 336 | 0% (0) | 37% | $27,290 |
| 2023 | 1,337 | 434 | 0% (0) | 30% | $73,619 |
| 2022 | 282 | 154 | 0% (0) | 48% | $40,310 |
| 2021 | 18 | None | 0% (0) | 0% | $79 |
| 2020 | 165 | 78 | 0% (0) | 8% | $20,390 |
| 2019 | 958 | 349 | 0% (0) | None | $54,592 |
| 2018 | 570 | 186 | None | 42% | $73,877 |
| 2017 | 1,404 | 270 | 0% (0) | 50% | $191,362 |
| 2016 | 1,784 | 340 | 0% (0) | 52% | $211,740 |
| 2015 | 1,690 | 355 | 0% (0) | 56% | $173,221 |
| 2014 | 1,114 | 267 | 0% (0) | 65% | $107,685 |
| 2013 | 624 | 142 | 0% (0) | 60% | $51,179 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Xiidra | 20 | $16,420 | $821 |
| Prednisolone Acetate | 271 | $9,033 | $33 |
| Latanoprost | 307 | $5,748 | $19 |
| Dorzolamide-Timolol | 238 | $5,159 | $22 |
| Alphagan P | 25 | $5,062 | $202 |
| Timolol Maleate | 58 | $3,020 | $52 |
| Diclofenac | 203 | $2,762 | $14 |
| Cyclosporine | 22 | $2,481 | $113 |
| Brimonidine | 45 | $1,394 | $31 |
| Dorzolamide | 33 | $869 | $26 |
| Erythromycin | 17 | $262 | $15 |
| Neomycin-Polymyxin-Dexameth | 17 | $216 | $13 |
| Doxycycline Monohydrate | 11 | $164 | $15 |
2022: 5 drugs
| Alphagan P | 17 | $3,223 | $190 |
| Latanoprost | 80 | $1,573 | $20 |
| Prednisolone Acetate | 35 | $1,394 | $40 |
| Dorzolamide-Timolol | 35 | $843 | $24 |
| Diclofenac | 18 | $226 | $13 |
2020: 4 drugs
| Dorzolamide-Timolol | 40 | $2,396 | $60 |
| Latanoprost | 60 | $1,545 | $26 |
| Brimonidine | 18 | $466 | $26 |
| Timolol Maleate | 11 | $302 | $27 |
2019: 12 drugs
| Prednisolone Acetate | 182 | $8,576 | $47 |
| Latanoprost | 228 | $5,323 | $23 |
| Dorzolamide-Timolol | 96 | $5,227 | $54 |
| Diclofenac | 158 | $4,299 | $27 |
| Timolol Maleate | 50 | $1,302 | $26 |
| Neomycin-Polymyxin-Dexameth | 46 | $1,122 | $24 |
| Brimonidine | 48 | $1,040 | $22 |
| Dorzolamide | 11 | $428 | $39 |
| Erythromycin | 19 | $403 | $21 |
| Doxycycline Monohydrate | 11 | $208 | $19 |
| Moxifloxacin | 11 | $185 | $17 |
| Amoxicillin | 11 | $64 | $6 |
2018: 11 drugs
| Combigan | 47 | $11,693 | $249 |
| Restasis | 12 | $11,614 | $968 |
| Alphagan P | 24 | $5,694 | $237 |
| Travatan Z | 14 | $4,898 | $350 |
| Latanoprost | 162 | $4,060 | $25 |
| Brimonidine | 33 | $2,770 | $84 |
| Cosopt Pf | 14 | $2,757 | $197 |
| Pazeo | 15 | $2,750 | $183 |
| Dorzolamide-Timolol | 83 | $2,298 | $28 |
| Timolol Maleate | 22 | $1,561 | $71 |
| Prednisolone Acetate | 15 | $781 | $52 |
2017: 23 drugs
| Restasis | 41 | $32,521 | $793 |
| Combigan | 81 | $19,952 | $246 |
| Alphagan P | 37 | $13,626 | $368 |
| Vigamox | 78 | $12,356 | $158 |
| Travatan Z | 28 | $10,350 | $370 |
| Prolensa | 41 | $9,686 | $236 |
| Lumigan | 20 | $8,279 | $414 |
| Brimonidine | 68 | $7,756 | $114 |
| Pazeo | 34 | $6,769 | $199 |
| Zioptan | 22 | $6,533 | $297 |
| Cosopt Pf | 26 | $6,177 | $238 |
| Durezol | 36 | $5,954 | $165 |
| Latanoprost | 299 | $5,825 | $19 |
| Prednisolone Acetate | 105 | $5,637 | $54 |
| Dorzolamide-Timolol | 178 | $4,893 | $27 |
| Ilevro | 16 | $4,160 | $260 |
| Lotemax | 18 | $3,153 | $175 |
| Simbrinza | 18 | $2,612 | $145 |
| Timolol Maleate | 15 | $1,580 | $105 |
| Diclofenac | 49 | $595 | $12 |
| Erythromycin | 23 | $305 | $13 |
| Neomycin-Polymyxin-Dexameth | 14 | $215 | $15 |
| Paroex | 12 | $40 | $3 |
2016: 25 drugs
| Restasis | 44 | $39,191 | $891 |
| Lumigan | 50 | $15,815 | $316 |
| Combigan | 85 | $15,206 | $179 |
| Travatan Z | 50 | $13,591 | $272 |
| Alphagan P | 49 | $13,450 | $274 |
| Vigamox | 85 | $13,356 | $157 |
| Ilevro | 44 | $12,438 | $283 |
| Brimonidine | 118 | $10,194 | $86 |
| Zioptan | 39 | $8,095 | $208 |
| Cosopt Pf | 42 | $7,252 | $173 |
| Prolensa | 30 | $7,154 | $238 |
| Prednisolone Acetate | 133 | $6,360 | $48 |
| Latanoprost | 378 | $6,313 | $17 |
| Dorzolamide-Timolol | 227 | $5,491 | $24 |
| Pazeo | 32 | $5,116 | $160 |
| Azopt | 11 | $4,398 | $400 |
| Lotemax | 21 | $4,051 | $193 |
| Durezol | 23 | $3,739 | $163 |
| Pataday | 14 | $3,181 | $227 |
| Diclofenac | 65 | $1,005 | $15 |
| Timolol Maleate | 39 | $913 | $23 |
| Neomycin-Polymyxin-Dexameth | 34 | $587 | $17 |
| Ofloxacin | 23 | $460 | $20 |
| Dorzolamide | 14 | $359 | $26 |
| Erythromycin | 20 | $255 | $13 |
2015: 25 drugs
| Restasis | 40 | $24,402 | $610 |
| Nevanac | 73 | $16,673 | $228 |
| Vigamox | 102 | $14,457 | $142 |
| Travatan Z | 64 | $12,607 | $197 |
| Combigan | 77 | $12,201 | $158 |
| Pataday | 66 | $11,609 | $176 |
| Lumigan | 54 | $10,897 | $202 |
| Prednisolone Acetate | 187 | $9,181 | $49 |
| Brimonidine | 82 | $9,073 | $111 |
| Alphagan P | 26 | $6,962 | $268 |
| Prolensa | 29 | $6,386 | $220 |
| Durezol | 38 | $5,920 | $156 |
| Ilevro | 23 | $5,689 | $247 |
| Latanoprost | 302 | $4,434 | $15 |
| Zioptan | 25 | $4,113 | $165 |
| Dorzolamide-Timolol | 149 | $3,373 | $23 |
| Simbrinza | 17 | $2,065 | $121 |
| Timolol Maleate | 40 | $1,910 | $48 |
| Diclofenac | 71 | $982 | $14 |
| Ofloxacin | 31 | $548 | $18 |
| Neomycin-Polymyxin-Dexameth | 27 | $468 | $17 |
| Gentamicin Sulfate | 48 | $463 | $10 |
| Dorzolamide | 12 | $390 | $33 |
| Levobunolol | 18 | $386 | $21 |
| Erythromycin | 23 | $309 | $13 |
2014: 18 drugs
| Nevanac | 102 | $18,618 | $183 |
| Restasis | 41 | $17,874 | $436 |
| Vigamox | 92 | $11,073 | $120 |
| Pataday | 71 | $9,995 | $141 |
| Prednisolone Acetate | 160 | $7,838 | $49 |
| Combigan | 44 | $6,756 | $154 |
| Travatan Z | 44 | $6,092 | $138 |
| Alphagan P | 32 | $4,854 | $152 |
| Latanoprost | 192 | $3,455 | $18 |
| Dorzolamide-Timolol | 94 | $3,272 | $35 |
| Azopt | 19 | $3,045 | $160 |
| Lumigan | 18 | $2,938 | $163 |
| Timolol Maleate | 19 | $811 | $43 |
| Neomycin-Polymyxin-Dexameth | 21 | $402 | $19 |
| Erythromycin | 24 | $377 | $16 |
| Clozapine | 11 | $340 | $31 |
| Levobunolol | 12 | $246 | $21 |
| Ofloxacin | 17 | $215 | $13 |
2013: 15 drugs
| Restasis | 41 | $11,122 | $271 |
| Nevanac | 48 | $7,061 | $147 |
| Travatan Z | 40 | $6,410 | $160 |
| Pataday | 50 | $6,392 | $128 |
| Vigamox | 46 | $4,675 | $102 |
| Dorzolamide-Timolol | 79 | $3,122 | $40 |
| Patanol | 18 | $2,981 | $166 |
| Azopt | 14 | $1,895 | $135 |
| Prednisolone Acetate | 67 | $1,701 | $25 |
| Latanoprost | 84 | $1,580 | $19 |
| Pilocarpine | 13 | $827 | $64 |
| Levobunolol | 25 | $769 | $31 |
| Clozapine | 13 | $427 | $33 |
| Neomycin-Polymyxin-Dexameth | 14 | $206 | $15 |
| Timolol Maleate | 19 | $190 | $10 |
Money from drug and device companies
$100 in 2025
| 2025 | 3 | 5 | None | $100 |
| 2024 | 2 | 11 | None | $341 |
| 2023 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Miebo | $41 | 2 payments
|
| Thea Pharma | Iyuzeh | $40 | 2 payments
|
| Alcon Vision | Eysuvis | $19 | 1 payment
|
See all 5 published payments
| Thea Pharma | Meals · 2025-10-31 | Iyuzeh | $16 |
| Thea Pharma | Meals · 2025-08-27 | Iyuzeh | $24 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Miebo | $21 |
| Alcon Vision | Meals · 2025-05-09 | Eysuvis | $19 |
| Bausch & Lomb Americas | Meals · 2025-04-14 | Vyzulta | $19 |
See earlier years (2024, 2023)
2024: $341
| Abbvie | Durysta | $321 | 10 payments
|
| Oyster Point Pharma | Tyrvaya | $20 | 1 payment
|
2023: $17
| Alcon Vision | Argos | $17 | 1 payment
|
Professional record
- NPI
- 1760474159
- Licence
- HI MD17321
- Trained
- University of California, Geffen School of Medicine, 1997 · 29 years ago
- Group
- Bdhv Medical Group of California PC · Ngoc Nguyen MD Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 220 Meridian Ave, San Jose, CA, 95126
- NPI first listed
- 2005-08-22
- NPI last updated
- 2025-02-28
- NPI record certified
- 2025-02-28
This is when the NPI record was last certified, not a medical board exam.